The invasive character of squamous cell carcinoma of the head and neck
represents a major challenge to the clinician since most often these
tumors require extensive surgical resection impairing important physio
logical functions including speech and swallowing. Additionally, in ma
ny cases costly reconstructive surgery is required to repair the adver
se cosmetic effects of the resective surgery. Thus, there is an urgent
need to understand the molecular mechanism(s) which underlie the loca
l and regional spread of this disease. Since the ability of tumor cell
s to invade into surrounding structures requires hydrolytic action muc
h effort has been spent on identifying the hydrolases involved in this
process. Some of the enzymes which have been implicated in the spread
of head and neck cancer include the urokinase-type plasminogen activa
tor and several members of the collagenase family such as type I and I
V collagenases and the stromelysins synthesized either by the tumor ce
lls or in the surrounding fibroblasts. More recent studies have addres
sed the mechanism(s) by which these hydrolases are overexpressed in in
vasive cancer. In the tumor cells themselves, work has focused on defi
ning the transcriptional requirements for enzyme synthesis and address
ing how the appropriate transcription factors are activated by signal
transduction pathways. In contrast, where the hydrolases (e.g. stromel
ysin-2 and stromelysin-3) are produced by the fibroblasts, current inv
estigations are directed at identifying tumor-derived growth factors w
hich lead to the inducible expression of the enzymes in the stromal ce
lls. The ultimate goal of these studies is to develop novel therapeuti
c interventions which decrease the invasive capacity of head and neck
cancer leading to longer survival times and enhanced quality of life f
or patients afflicted with this disease.